Plasma PAI-1 levels in obese children - Effect of weight loss and influence of PAI-1 promoter 4G/5G genotype

Thrombosis and Haemostasis

Volumn 86, Issue 2, 2001, Pages 647-652

  Estelles A ^a   Dalmau, J ^a   Falco C ^a   Berbel, O ^a   Castello R ^a   Espana F ^a   Aznar, J ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Hypofibrinolysis; Obese children; PAI 1 genotype

Indexed keywords

CARBOHYDRATE; CHOLESTEROL; FIBRINOGEN; GLUCOSE; INSULIN; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ADIPOCYTE; ADOLESCENT; AGE; AGE DISTRIBUTION; ALLELE; ANTHROPOMETRY; ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; DIET; DISEASE ASSOCIATION; EXERCISE; FEMALE; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; HEMOSTASIS; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATION; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SEX; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0034902609     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616100     Document Type: Article

References (40)

1. American Heart Association call to action: Obesity as a major risk factor for coronary heart disease
2. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects
3. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
4. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo: Induction by tumor necrosis factor-α and lipopolysaccharide
5. 1 and BMI are closely associated in human adipose tissue during morbid obesity
6. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue
7. Regulation of PAI-1 gene expression
8. Structure of plasminogen activator inhibitor-1 (PAI-1) and its function in fibrinolysis: An update
9. Insulin stimulates the synthesis of plasminogen activator inhibitor-1 by the human hepatocellular cell line HepG2
10. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor (PAI-1) gene respond differently to interleukin-1 in hepG2 cell
11. Allele-specific increase in basal transcription of the plasminogenactivator inhibitor 1 gene is associated with myocardial infarction
12. The PAI1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease
13. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor1 (PAI1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study
14. The 4G/5G sequence polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene: Relationship to plasma PAI-1 levels in venous thromboembolism
15. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis
16. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects
17. Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus
18. 4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in italians: A model of gene-environment interaction
19. Reduced fibrinolytic response in obese children: Association with high baseline activity of the fast acting plasminogen activator inhibitor (PAI-1)
20. Fat distribution and hemostatic measures in obese children
21. Infantile obesity: A situation of atherothrombotic risk?
22. Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: Effect of dieting with or without exercise in overweight postmenopausal women
23. Impact of adipose tissue on plasma plasminogen inhibitor-1 in dieting obese women
24. Effects of physical training and its cessation on hemostatic system in obese children
25. Reference data for obesity: 85th and 95th percentiles of body mass index and triceps skinfold thickness
26. Curvas y tablas de crecimiento. Instituto de Investigaciones sobre crecimiento y desarrollo
27. Obesity in children
28. Euglobulin clot lysis induced by tissue-type plasminogen activator is reduced in subjects with increased levels of lipoprotein(a)
29. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation
30. Method for the determination of functional (clottable) fibrinogen by the new family of ASL coagulometers
31. An alternative method for PAI-1 promoter polymorphism (4G/5G) typing
32. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease. Influence of hormone replacement therapy
33. Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians
34. Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen concentrations. A family study with part of the Stanislas cohort
35. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents
36. Determinants of haemostatic risk factors for coronary heart disease in obese children and adolescents
37. Fibrinolytic activity, clotting factors, and longterm incidence of ischaemic heart disease in the Northwick Park Heart Study
38. High plasminogen activator inhibitor and tissue plasminogen levels in plasma precede a first acute myocardial infarction in both men and women. Evidence for the fibrinolytic system as an independent primary risk factor
39. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease
40. Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue